{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:29:20Z","timestamp":1740166160464,"version":"3.37.3"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s13760-022-01893-5","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T19:02:44Z","timestamp":1644692564000},"page":"1373-1375","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acute leukoencephalopathy and thyroiditis induced by capecitabine"],"prefix":"10.1007","volume":"122","author":[{"given":"M.","family":"Mossakowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Hanseeuw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Duprez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3454-0630","authenticated-orcid":false,"given":"C.","family":"Van Marcke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,12]]},"reference":[{"key":"1893_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuro.2017.05.001","volume":"62","author":"M Obadia","year":"2017","unstructured":"Obadia M, Leclercq D, Wasserman J et al (2017) Capecitabine-induced acute toxic leukoencephalopathy. Neurotoxicology 62:1\u20135","journal-title":"Neurotoxicology"},{"key":"1893_CR2","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1177\/1078155220914704","volume":"26","author":"M Monti","year":"2020","unstructured":"Monti M, Barone D, Amadori E et al (2020) Posterior reversible encephalopathy syndrome: a rare neurotoxicity after capecitabine. J Oncol Pharm Pract 26:1795\u20131801","journal-title":"J Oncol Pharm Pract"},{"key":"1893_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/path.1711760212","volume":"176","author":"SB Fox","year":"1995","unstructured":"Fox SB, Moghaddam A, Westwood M et al (1995) Platelet-derived endothelial cell growth factor\/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol 176:183\u2013190","journal-title":"J Pathol"},{"key":"1893_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/cncr.30321","volume":"123","author":"WW Ma","year":"2017","unstructured":"Ma WW, Saif MW, El-Rayes BF et al (2017) Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity. Cancer 123:345\u2013356","journal-title":"Cancer"},{"key":"1893_CR5","first-page":"1","volume":"2016","author":"A Bougea","year":"2016","unstructured":"Bougea A, Voskou P, Kilidireas C et al (2016) Capecitabine induced multifocal leukoencephalopathy: do we have always to switch off the chemotherapy? Case Rep Oncol Med 2016:1\u20133","journal-title":"Case Rep Oncol Med"},{"key":"1893_CR6","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3892\/or.2013.2644","volume":"30","author":"Y Fujiwara","year":"2013","unstructured":"Fujiwara Y, Chayahara N, Mukohara T et al (2013) Hypothyroidism in patients with colorectal carcinoma treated with fluoropyrimidines. Oncol Rep 30:1802\u20131806","journal-title":"Oncol Rep"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-022-01893-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-022-01893-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-022-01893-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T08:11:13Z","timestamp":1664093473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-022-01893-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,12]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1893"],"URL":"https:\/\/doi.org\/10.1007\/s13760-022-01893-5","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"type":"print","value":"0300-9009"},{"type":"electronic","value":"2240-2993"}],"subject":[],"published":{"date-parts":[[2022,2,12]]},"assertion":[{"value":"22 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethics committee of Cliniques universitaires Saint-Luc approved the study. Informed consent was obtained from the patient. All the procedures performed were part of the routine care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement and Informed consent"}}]}}